anmelden
SMI
13.240,70
PKT
+20,53
PKT
+0,16
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.01.17 | Swiss Re Underperform | Jefferies & Company Inc. | |
| 17.01.17 | Nestlé buy | Deutsche Bank AG | |
| 17.01.17 | Givaudan buy | Deutsche Bank AG | |
| 16.01.17 | Swiss Re Underperform | Credit Suisse Group | |
| 16.01.17 | Nestlé buy | UBS AG | |
| 16.01.17 | Zurich Insurance Outperform | Credit Suisse Group | |
| 16.01.17 | Swiss Re Sell | UBS AG | |
| 16.01.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 16.01.17 | UBS buy | Goldman Sachs Group Inc. | |
| 16.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.01.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 13.01.17 | UBS Underperform | Macquarie Research | |
| 13.01.17 | Roche overweight | Morgan Stanley | |
| 13.01.17 | Swiss Re buy | HSBC | |
| 13.01.17 | Zurich Insurance buy | HSBC | |
| 12.01.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.01.17 | Zurich Insurance Sell | Société Générale Group S.A. (SG) | |
| 12.01.17 | Roche overweight | JP Morgan Chase & Co. | |
| 12.01.17 | Roche buy | Deutsche Bank AG | |
| 12.01.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 12.01.17 | Givaudan overweight | JP Morgan Chase & Co. | |
| 12.01.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
| 11.01.17 | UBS buy | Société Générale Group S.A. (SG) | |
| 11.01.17 | UBS buy | Citigroup Corp. | |
| 11.01.17 | UBS buy | Citigroup Corp. | |
| 11.01.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 11.01.17 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 11.01.17 | ABB (Asea Brown Boveri) buy | Merrill Lynch & Co., Inc. | |
| 11.01.17 | Nestlé buy | UBS AG | |
| 10.01.17 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 10.01.17 | UBS buy | UBS AG | |
| 10.01.17 | UBS buy | UBS AG | |
| 09.01.17 | Novartis Hold | Deutsche Bank AG | |
| 09.01.17 | Holcim buy | Deutsche Bank AG | |
| 09.01.17 | Roche buy | Deutsche Bank AG | |
| 09.01.17 | UBS Underperform | Merrill Lynch & Co., Inc. | |
| 09.01.17 | UBS buy | Merrill Lynch & Co., Inc. | |
| 06.01.17 | Holcim buy | Deutsche Bank AG | |
| 06.01.17 | Givaudan buy | Deutsche Bank AG | |
| 06.01.17 | Holcim market-perform | Bernstein Research |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.